Study Evaluating the Efficacy and Safety of OCS-01 Eye Drops in Subjects Following Cataract Surgery
Public ClinicalTrials.gov record NCT06128369. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-masked, Vehicle-controlled Study Evaluating the Efficacy and Safety of OCS-01 Ophthalmic Suspension in the Treatment of Inflammation and Pain Following Cataract Surgery
Study identification
- NCT ID
- NCT06128369
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Oculis
- Industry
- Enrollment
- 117 participants
Conditions and interventions
Conditions
Interventions
- Dexamethasone Ophthalmic Suspension Drug
- Vehicle of OCS-01 Other
Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 17, 2023
- Primary completion
- May 1, 2024
- Completion
- May 8, 2024
- Last update posted
- Dec 9, 2024
2023 – 2024
United States locations
- U.S. sites
- 12
- U.S. states
- 9
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Oculis Investigative Site | Inglewood | California | 90301 | — |
| Oculis Investigative Site | Morrow | Georgia | 30260 | — |
| Oculis Investigative Site | Louisville | Kentucky | 40206 | — |
| Oculis Investigative Site | St Louis | Missouri | 63131 | — |
| Oculis Investigative Site | Washington | Missouri | 63090 | — |
| Oculis Investigative Site | Elizabeth City | North Carolina | 27909 | — |
| Oculis Investigative Site | Eugene | Oregon | 97401 | — |
| Oculis Investigative Site | Kingston | Pennsylvania | 18704 | — |
| Oculis Investigative Site | Austin | Texas | 78731 | — |
| Oculis Investigative Site | Houston | Texas | 77008 | — |
| Oculis Investigative Site | San Antonio | Texas | 78229 | — |
| Oculis Investigative Site | Lynchburg | Virginia | 24502 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06128369, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 9, 2024 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06128369 live on ClinicalTrials.gov.